Diebold Nixdorf Incorporated Common stock (DBD) stock analysis
DBD · Diebold Nixdorf Incorporated Common stock
Latest recorded price: USD 52.93
Model-estimated fair value: USD 25.30. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Technology · Software - Application
At $52.93, DBD trades 109.2% above the model's base-case value of $25.30. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $15.48 in the conservative case and $33.64 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 3.2%, ROIC 10.3%. The model does not flag any risk signals for this company.